These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 4625922)

  • 1. The inactivation of bradykinin in the pulmonary circulation of isolated lungs.
    Alabaster VA; Bakhle YS
    Br J Pharmacol; 1972 Jun; 45(2):299-310. PubMed ID: 4625922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Converting enzyme and bradykininase in the lung.
    Alabaster VA; Bakhle YS
    Circ Res; 1972 Sep; 31(9):Suppl 2:72-84. PubMed ID: 4341482
    [No Abstract]   [Full Text] [Related]  

  • 3. The bradykininase activities of extracts of dog lung.
    Alabaster VA; Bakhle YS
    Br J Pharmacol; 1973 Apr; 47(4):799-807. PubMed ID: 4723801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary metabolism of bradykinin analogues and the contribution of angiotensin converting enzyme to bradykinin inactivation in isolated lungs.
    Bakhle YS
    Br J Pharmacol; 1977 Jan; 59(1):123-8. PubMed ID: 189870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible involvement of angiotensin I-converting enzyme in the inactivation of bradykinin by intact macrophages.
    Nagaoka I; Yamashita T
    Biochim Biophys Acta; 1986 Apr; 886(2):231-42. PubMed ID: 3008853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The C-type natriuretic peptide precursor of snake brain contains highly specific inhibitors of the angiotensin-converting enzyme.
    Hayashi MA; Murbach AF; Ianzer D; Portaro FC; Prezoto BC; Fernandes BL; Silveira PF; Silva CA; Pires RS; Britto LR; Dive V; Camargo AC
    J Neurochem; 2003 May; 85(4):969-77. PubMed ID: 12716428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo pulmonary metabolism of bradykinin, angiotensin I and 5-hydroxtryptamine in the rat.
    Freer RJ; Stewart JM
    Arch Int Pharmacodyn Ther; 1975 Sep; 217(1):97-109. PubMed ID: 172037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bradykinin potentiating peptide PCA-Lys-Trp-Ala-Pro. An inhibitor of the pulmonary inactivation of bradykinin and conversion of angiotensin I to II.
    Stewart JM; Ferreira SH; Greene LJ
    Biochem Pharmacol; 1971 Jul; 20(7):1557-67. PubMed ID: 4355304
    [No Abstract]   [Full Text] [Related]  

  • 9. On the potentiation of kinins by sulfhydrylic compounds.
    Auerswald W; Doleschel W
    Arch Int Pharmacodyn Ther; 1967 Jul; 168(1):188-98. PubMed ID: 4292761
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of human fibrinopeptide A upon the responses to, and the metabolism of bradykinin.
    Bunn DR
    Bibl Anat; 1973; 12():443-8. PubMed ID: 4790381
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of captopril on the bradykinin-induced release of prostacyclin from guinea-pig lungs and bovine aortic endothelial cells.
    de Nucci G; Warner T; Vane JR
    Br J Pharmacol; 1988 Nov; 95(3):783-8. PubMed ID: 2850062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do the cardiovascular effects of angiotensin-converting enzyme (ACE) I involve ACE-independent mechanisms? new insights from proline-rich peptides of Bothrops jararaca.
    Ianzer D; Santos RA; Etelvino GM; Xavier CH; de Almeida Santos J; Mendes EP; Machado LT; Prezoto BC; Dive V; de Camargo AC
    J Pharmacol Exp Ther; 2007 Aug; 322(2):795-805. PubMed ID: 17475904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and characterization of a novel bradykinin potentiating peptide (BPP) from the skin secretion of Phyllomedusa hypochondrialis.
    Conceição K; Konno K; de Melo RL; Antoniazzi MM; Jared C; Sciani JM; Conceição IM; Prezoto BC; de Camargo AC; Pimenta DC
    Peptides; 2007 Mar; 28(3):515-23. PubMed ID: 17098329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. INHIBITION IN VIVO OF THE ENZYMATIC INACTIVATION OF BRADYKININ AND KALLIDIN.
    ERDÖS EG; WOHLER JR
    Biochem Pharmacol; 1963 Oct; 12():1193-9. PubMed ID: 14074119
    [No Abstract]   [Full Text] [Related]  

  • 15. Inactivation of bradykinin the plumonary circulation.
    Stewart JM
    Agents Actions; 1976 Jul; 6(4):494-7. PubMed ID: 961547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-identity between pulmonary bradykininase and converting-enzyme activity.
    Scholz HW; Biron P
    Rev Can Biol; 1969 Sep; 28(3):197-200. PubMed ID: 4310618
    [No Abstract]   [Full Text] [Related]  

  • 17. The removal of noradrenaline in the pulmonary circulation of rat isolated lungs.
    Alabaster VA; Bakhle YS
    Br J Pharmacol; 1973 Feb; 47(2):325-31. PubMed ID: 4722046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of asbestos on the metabolism of vasoactive substances in isolated perfused guinea pig lungs.
    Cadieux A; Massé S; Sirois P
    Environ Health Perspect; 1983 Sep; 51():287-91. PubMed ID: 6580166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the conversion of angiotensin I to II and potentiation of bradykinin by small peptides present in Bothrops jararaca venom.
    Greene LJ; Camargo AC; Krieger EM; Stewart JM; Ferreira SH
    Circ Res; 1972 Sep; 31(9):Suppl 2:62-71. PubMed ID: 4341481
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetic function of the pulmonary circulation.
    Bakhle YS; Vane JR
    Physiol Rev; 1974 Oct; 54(4):1007-45. PubMed ID: 4371230
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.